• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对醛糖还原酶的癌症治疗方法。

Targeting aldose reductase for the treatment of cancer.

机构信息

Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555, USA.

出版信息

Curr Cancer Drug Targets. 2011 Jun;11(5):560-71. doi: 10.2174/156800911795655958.

DOI:10.2174/156800911795655958
PMID:21486217
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3142792/
Abstract

It is strongly established by numerous studies that oxidative stress-induced inflammation is one of the major causative agents in a variety of cancers. Various factors such as bacterial, viral, parasitic infections, chemical irritants, carcinogens are involved in the initiation of oxidative stress-mediated inflammation. Chronic and persistent inflammation promotes the formation of cancerous tumors. Recent investigations strongly suggest that aldose reductase [AR; AKR1B1], a member of aldo-keto reductase superfamily of proteins, is the mediator of inflammatory signals induced by growth factors, cytokines, chemokines, carcinogens etc. Further, AR reduced product(s) of lipid derived aldehydes and their metabolites such as glutathionyl 1,4-dihydroxynonanol (GS-DHN) have been shown to be involved in the activation of transcription factors such as NF-κB and AP-1 which transcribe the genes of inflammatory cytokines. The increased inflammatory cytokines and growth factors promote cell proliferation, a main feature involved in the tumorigenesis process. Inhibition of AR has been shown to prevent cancer cell growth in vitro and in vivo models. In this review, we have described the possible association between AR with oxidative stress- and inflammation- initiated carcinogenesis. A thorough understanding of the role of AR in the inflammation -associated cancers could lead to the use of AR inhibitors as novel chemotherapeutic agents against cancer.

摘要

大量研究证实,氧化应激诱导的炎症是多种癌症的主要致病因素之一。细菌、病毒、寄生虫感染、化学刺激物、致癌物质等各种因素都参与了氧化应激介导的炎症的启动。慢性和持续性炎症促进了癌性肿瘤的形成。最近的研究强烈表明,醛糖还原酶[AR;AKR1B1]是生长因子、细胞因子、趋化因子、致癌物质等诱导的炎症信号的介质。此外,已经表明 AR 还原的脂质衍生醛及其代谢物(如谷胱甘肽基 1,4-二羟壬醇(GS-DHN))参与转录因子如 NF-κB 和 AP-1 的激活,这些转录因子转录炎症细胞因子的基因。增加的炎症细胞因子和生长因子促进细胞增殖,这是肿瘤发生过程中的一个主要特征。本综述描述了 AR 与氧化应激和炎症引发的致癌作用之间的可能关联。深入了解 AR 在炎症相关癌症中的作用可能导致使用 AR 抑制剂作为新型化疗药物来对抗癌症。

相似文献

1
Targeting aldose reductase for the treatment of cancer.针对醛糖还原酶的癌症治疗方法。
Curr Cancer Drug Targets. 2011 Jun;11(5):560-71. doi: 10.2174/156800911795655958.
2
Aldose reductase mediates the lipopolysaccharide-induced release of inflammatory mediators in RAW264.7 murine macrophages.醛糖还原酶介导脂多糖诱导RAW264.7小鼠巨噬细胞释放炎症介质。
J Biol Chem. 2006 Nov 3;281(44):33019-29. doi: 10.1074/jbc.M603819200. Epub 2006 Sep 6.
3
Inhibition of aldose reductase prevents experimental allergic airway inflammation in mice.醛糖还原酶抑制剂可预防小鼠实验性变应性气道炎症。
PLoS One. 2009 Aug 6;4(8):e6535. doi: 10.1371/journal.pone.0006535.
4
Aldose reductase regulates growth factor-induced cyclooxygenase-2 expression and prostaglandin E2 production in human colon cancer cells.醛糖还原酶调节生长因子诱导的人结肠癌细胞中环氧合酶-2的表达及前列腺素E2的产生。
Cancer Res. 2006 Oct 1;66(19):9705-13. doi: 10.1158/0008-5472.CAN-06-2105.
5
Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disorders.醛糖还原酶抑制作用可抑制氧化应激诱导的炎症紊乱。
Chem Biol Interact. 2011 May 30;191(1-3):330-8. doi: 10.1016/j.cbi.2011.02.023. Epub 2011 Feb 24.
6
Aldose reductase inhibition suppresses the expression of Th2 cytokines and airway inflammation in ovalbumin-induced asthma in mice.醛糖还原酶抑制可抑制卵清蛋白诱导的小鼠哮喘中Th2细胞因子的表达和气道炎症。
J Immunol. 2009 Oct 1;183(7):4723-32. doi: 10.4049/jimmunol.0901177. Epub 2009 Sep 14.
7
Mediation of aldose reductase in lipopolysaccharide-induced inflammatory signals in mouse peritoneal macrophages.醛糖还原酶在脂多糖诱导的小鼠腹腔巨噬细胞炎症信号中的介导作用。
Cytokine. 2006 Nov;36(3-4):115-22. doi: 10.1016/j.cyto.2006.11.003. Epub 2006 Dec 15.
8
Aldose reductase inhibitor, fidarestat prevents doxorubicin-induced endothelial cell death and dysfunction.醛糖还原酶抑制剂,法地瑞司他可预防阿霉素诱导的内皮细胞死亡和功能障碍。
Biochem Pharmacol. 2018 Apr;150:181-190. doi: 10.1016/j.bcp.2018.02.018. Epub 2018 Feb 16.
9
Aldose reductase inhibition suppresses azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-db/db mice.醛糖还原酶抑制作用可抑制氧化偶氮甲烷诱导的C57BL/KsJ-db/db小鼠结肠癌前病变。
Cancer Lett. 2014 Dec 1;355(1):141-7. doi: 10.1016/j.canlet.2014.09.006. Epub 2014 Sep 10.
10
Aldo-keto reductases: Role in cancer development and theranostics.醛酮还原酶:在癌症发生发展和治疗中的作用。
Oncol Res. 2024 Jul 17;32(8):1287-1308. doi: 10.32604/or.2024.049918. eCollection 2024.

引用本文的文献

1
Targeting AKR1B1 inhibits metabolic reprogramming to reverse systemic therapy resistance in hepatocellular carcinoma.靶向AKR1B1可抑制代谢重编程,从而逆转肝细胞癌的全身治疗耐药性。
Signal Transduct Target Ther. 2025 Aug 1;10(1):244. doi: 10.1038/s41392-025-02321-9.
2
Bioactive potential of Tripleurospermum inodorum with detailed insight into anti-inflammatory activity through in vitro, in vivo evaluations and network pharmacology.臭甘菊的生物活性潜力,通过体外、体内评估和网络药理学对其抗炎活性进行深入研究。
Inflammopharmacology. 2025 May 7. doi: 10.1007/s10787-025-01769-z.
3
Unveiling the Potential of S4 on Non-small Cell Lung Cancer Cells: Impact on Proliferation, Apoptosis, Senescence, and Metabolome Profile.

本文引用的文献

1
Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disorders.醛糖还原酶抑制作用可抑制氧化应激诱导的炎症紊乱。
Chem Biol Interact. 2011 May 30;191(1-3):330-8. doi: 10.1016/j.cbi.2011.02.023. Epub 2011 Feb 24.
2
Global cancer statistics.全球癌症统计数据。
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90. doi: 10.3322/caac.20107. Epub 2011 Feb 4.
3
Diagnosis and management of dysplasia and cancer of the ileal pouch in patients with underlying inflammatory bowel disease.炎症性肠病患者回肠贮袋相关发育不良和癌症的诊断和治疗。
揭示S4对非小细胞肺癌细胞的潜在作用:对增殖、凋亡、衰老和代谢组谱的影响
Anticancer Agents Med Chem. 2025;25(11):785-799. doi: 10.2174/0118715206350735241224073200.
4
Quercetin Derivatives from Bidens pilosa Suppressed Cell Proliferation via Inhibition of RSK2 Kinase and Aldose Reductase Enzymes: UPLC-MS/MS, GC-MS, In Vitro, and Computational Studies.来自鬼针草的槲皮素衍生物通过抑制RSK2激酶和醛糖还原酶来抑制细胞增殖:超高效液相色谱-串联质谱、气相色谱-质谱、体外及计算研究
Appl Biochem Biotechnol. 2025 Apr;197(4):2474-2492. doi: 10.1007/s12010-024-05134-8. Epub 2025 Jan 6.
5
Aldo-keto reductases: Role in cancer development and theranostics.醛酮还原酶:在癌症发生发展和治疗中的作用。
Oncol Res. 2024 Jul 17;32(8):1287-1308. doi: 10.32604/or.2024.049918. eCollection 2024.
6
The p53 tumor suppressor regulates AKR1B1 expression, a metastasis-promoting gene in breast cancer.p53肿瘤抑制因子调控AKR1B1的表达,AKR1B1是一种促进乳腺癌转移的基因。
Front Mol Biosci. 2023 Sep 14;10:1145279. doi: 10.3389/fmolb.2023.1145279. eCollection 2023.
7
Discovery of Phenylcarbamoylazinane-1,2,4-Triazole Amides Derivatives as the Potential Inhibitors of Aldo-Keto Reductases (AKR1B1 & AKRB10): Potential Lead Molecules for Treatment of Colon Cancer.苯甲酰胺嗪烷-1,2,4-三唑酰胺衍生物的发现作为醛酮还原酶(AKR1B1 和 AKRB10)的潜在抑制剂:用于治疗结肠癌的潜在先导分子。
Molecules. 2022 Jun 21;27(13):3981. doi: 10.3390/molecules27133981.
8
Overcoming Drug Resistance in Advanced Prostate Cancer by Drug Repurposing.通过药物再利用克服晚期前列腺癌的耐药性。
Med Sci (Basel). 2022 Feb 18;10(1):15. doi: 10.3390/medsci10010015.
9
Aldehyde Dehydrogenase 2 Family Member (ALDH2) Is a Therapeutic Index for Oxaliplatin Response on Colorectal Cancer Therapy with Dysfunction p53.醛脱氢酶 2 家族成员(ALDH2)是结直肠癌治疗中 p53 功能障碍对奥沙利铂反应的治疗指标。
Biomed Res Int. 2022 Feb 7;2022:1322788. doi: 10.1155/2022/1322788. eCollection 2022.
10
Anticancer Activity of Ω-6 Fatty Acids through Increased 4-HNE in Breast Cancer Cells.Ω-6脂肪酸通过增加乳腺癌细胞中的4-羟基壬烯醛发挥抗癌活性。
Cancers (Basel). 2021 Dec 20;13(24):6377. doi: 10.3390/cancers13246377.
Cancer. 2011 Jul 15;117(14):3081-92. doi: 10.1002/cncr.25886. Epub 2011 Jan 24.
4
Mechanisms of tumor promotion by reactive oxygen species.活性氧诱导肿瘤促进的机制。
Biochemistry (Mosc). 2010 Jun;75(6):675-85. doi: 10.1134/s0006297910060015.
5
Inflammation-mediated promotion of invasion and metastasis.炎症介导促进侵袭和转移。
Cancer Metastasis Rev. 2010 Jun;29(2):243-8. doi: 10.1007/s10555-010-9227-2.
6
Inhibition of aldose reductase prevents growth factor-induced G1-S phase transition through the AKT/phosphoinositide 3-kinase/E2F-1 pathway in human colon cancer cells.醛糖还原酶抑制剂通过 AKT/磷酸肌醇 3-激酶/E2F-1 通路抑制人结肠癌细胞中生长因子诱导的 G1-S 期转换。
Mol Cancer Ther. 2010 Apr;9(4):813-24. doi: 10.1158/1535-7163.MCT-09-0795. Epub 2010 Mar 30.
7
The role of infection in the aetiology of inflammatory bowel disease.感染在炎症性肠病发病机制中的作用。
J Gastroenterol. 2010 Mar;45(3):266-76. doi: 10.1007/s00535-009-0191-y.
8
Novel role for aldose reductase in mediating acute inflammatory responses in the lung.醛糖还原酶在介导肺部急性炎症反应中的新作用。
J Immunol. 2009 Dec 15;183(12):8128-37. doi: 10.4049/jimmunol.0900720.
9
Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways.炎症与癌症:miRNA、自由基、细胞因子与 p53 通路的交织。
Carcinogenesis. 2010 Jan;31(1):37-49. doi: 10.1093/carcin/bgp272. Epub 2009 Dec 2.
10
Multidrug resistance in cancer.癌症中的多药耐药性。
Methods Mol Biol. 2010;596:1-14. doi: 10.1007/978-1-60761-416-6_1.